Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

Published on by Infectious

Dr. Shayan Zamani | Antiviral Therapies and Resistance Mechanisms | Best Researcher Award

MD | Tehran University of Medical Sciences | Iran

Dr. Shayan Zamani is a dedicated Clinical Research Fellow at the Center for Research and Training in Skin Diseases and Leprosy, Tehran University of Medical Sciences, where he has established a strong foundation in dermatology, oncology, and hematopoietic stem cell transplantation. He earned his Doctor of Medicine (MD) with a focus on dermatologic research and clinical therapeutics, combining his medical expertise with evidence-based research in complex dermatological and oncologic disorders. Throughout his career, Dr. Zamani has contributed to multidisciplinary research collaborations exploring topics such as graft-versus-host disease (GVHD), drug-resistant fungal infections, cutaneous complications in oncology patients, and innovative nanoliposomal treatments for fungal and inflammatory skin diseases. His professional experience spans both clinical and laboratory environments, where he integrates translational methodologies to improve diagnostic precision and patient outcomes. His research interests center on dermatologic oncology, infectious skin diseases, immunodermatology, and regenerative therapies, supported by his skills in clinical trial design, biomarker analysis, molecular diagnostics, and data-driven evaluation of treatment efficacy. Dr. Zamani has authored several peer-reviewed publications in reputable journals such as JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Frontiers in Oncology, and Dermatologic Therapy, contributing valuable insights into skin disease pathophysiology and treatment optimization. His work has earned him recognition for academic excellence and commitment to advancing medical science. Dr. Zamani has actively participated in research collaborations and conferences, reflecting strong leadership and dedication to clinical innovation. With a growing publication record and a clear focus on improving therapeutic outcomes, he continues to strengthen his role in advancing dermatologic and oncologic research globally. His academic impact is demonstrated by 19 citations , 11 publications, and an h-index of 3.

Profiles : Google Scholar | Scopus | ORCID

Featured Publications

1. Tamimi, P., Fattahi, M., Ghaderi, A., Firooz, A., Shirvani, F., Alkhen, A., & Zamani, S. (2024). Terbinafin‐resistente Trichophyton indotineae mit F397L/L393S‐ oder F397L/L393F‐Mutation bei Patienten mit Tinea incognita unter Glukokortikosteroiden. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 22(7), 922–935.

2. Samadi, A., Ayatollahi, A., Kashani, M. N., Zamani, S., & Firooz, A. (2023). Efficacy and tolerability assessment of a polynucleotide‐based gel for improvement of pattern hair loss: A polynucleotide‐based gel for improvement of pattern hair loss. [Journal name not specified].

3. Mehdizadeh, M., Tehrani, H. A., Rezvani, H., Zamani, S., Salari, S., & Hajifathali, A. (2023). Maintenance therapy with Everolimus in patients with refractory or relapsing Hodgkin lymphoma after autologous stem cell transplantation. Blood Cell Therapy, 6(3), 87–93.

4. Zamani, S., Azhdari, H., & Mehdizadeh, M. (2023). Efficacy and safety profile of Everolimus as a maintenance therapy for primary refractory/relapsing Hodgkin lymphoma following autologous hematopoietic stem cell transplantation. HemaSphere, 7(S3), e9236902.

5. Zamani, S., Mehdizadeh, M., & Salem, A. (2023). Allogeneic stem cell transplantation outcomes in Hodgkin lymphoma: A prognostic study of 30 patients with relapsed and refractory Hodgkin lymphoma. HemaSphere, 7(S3), e621289b.

 

Hassan Babamohamadi | Viral Infections | Best Researcher Award

Published on by Infectious

Prof. Dr. Hassan Babamohamadi | Viral Infections | Best Researcher Award

Clinical Trial | Semnan University of Medical Sciences | Iran

Dr. Hassan Babamohamadi is a distinguished Professor of Nursing at Semnan University of Medical Sciences, Iran, recognized for his extensive contributions to nursing education, clinical practice, and research. His scholarly work encompasses diverse areas, including medical education, critical thinking, spinal cord injury, hemodialysis care, pain management, chronic disease adjustment, psychometrics, and complementary medicine. He has played a key role in advancing the quality of nursing curricula through numerous comparative studies evaluating Iranian nursing programs against international standards, contributing significantly to the development of evidence-based educational frameworks. His clinical research has explored innovative interventions such as spiritual care models, acupressure, aromatherapy, rhythmic breathing, and family-based participatory programs, offering valuable insights into patient recovery, mental health, and holistic well-being. With a strong focus on both qualitative and quantitative methodologies, Dr. Babamohamadi’s studies emphasize improving patient outcomes, enhancing healthcare professionals’ competencies, and integrating ethical and spiritual dimensions into modern nursing. His publications in prestigious journals like BMC Nursing, Journal of Religion and Health, Complementary Therapies in Medicine, and Australian Critical Care highlight his commitment to interdisciplinary research and global academic collaboration. In addition to his prolific research output, he has contributed as an editorial board member and peer reviewer for several reputable journals, supporting the advancement of nursing science and evidence-based clinical practice. His leadership roles within academic administration, including serving as head of the Medical-Surgical Nursing Department and vice chancellor of education, reflect his dedication to academic excellence and institutional development. Dr. Babamohamadi’s research continues to influence the evolution of nursing education and clinical innovation, strengthening the bridge between theory and practice across health sciences. 3806 Citations, 56 Documents, 17 h-index, View h-index.

Profiles : Google Scholar | Scopus| ORCID

Featured Publications

Ong, K. L., Stafford, L. K., McLaughlin, S. A., Boyko, E. J., Vollset, S. E., Smith, A. E., … (2023). Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. The Lancet, 402(10397), 203–234.Cited by 3415

Shin, Y. H., Hwang, J., Kwon, R., Lee, S. W., Kim, M. S., … (2023). Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study. Allergy, 78(8), 2232–2254.Cited by 298

Safdarian, M., Trinka, E., Rahimi-Movaghar, V., Thomschewski, A., Aali, A., … (2023). Global, regional, and national burden of spinal cord injury, 1990–2019: A systematic analysis for the Global Burden of Disease Study 2019. The Lancet Neurology, 22(11), 1026–1047.Cited by 216

Pourteimour, S., Yaghmaei, S., & Babamohamadi, H. (2021). The relationship between mental workload and job performance among Iranian nurses providing care to COVID‐19 patients: A cross-sectional study. Journal of Nursing Management, 29(6), 1723–1732.Cited by 206

Bender, R. G., Sirota, S. B., Swetschinski, L. R., Dominguez, R. M. V., Novotney, A., … (2024). Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: A systematic analysis from the Global Burden of Disease Study. The Lancet Infectious Diseases, 24(9), 974–1002.Cited by 203